SLC7A11 and neoplasm: There was good concordance between SLC7A11 (which encodes xCT), NQO1, GCLC and GCLM median expression levels across tumours (Fig. 5a), providing an ‘antioxidant signature’ associated with the NRF2 transcriptional programme.